title: Intratracheally administered pathogen-associated molecular patterns affect antibody responses of poultry.
abstract: Various potential immune-modulating microbially derived pathogen-associated molecular patterns (PAMP), or so called homotopes, are present in high concentrations in the environment of food animals. In previous studies, intravenously administered PAMP had variable effects on specific primary and secondary immune responses of poultry to systemically administered antigens. In the present study, we evaluated the effects of intratracheal (i.t.) challenge with the PAMP lipopolysaccharide, lipoteichoic acid (LTA), and Zymosan-A (containing 1,3 beta-glucan) on primary and secondary (total) antibody (Ab) responses and (isotype) IgM, IgG, and IgA responses to systemically administered human serum albumin (HuSA), and Ab titers to infectious bursal disease (Gumboro virus) and infectious bronchitis vaccines in layer hens at 9 and 22 wk of age. Birds were challenged via the trachea with PAMP for 5 consecutive days prior to primary and secondary immunization with HuSA. Intratracheally administered LTA and, to a minor extent, lipopolysaccharide significantly enhanced secondary total and IgG Ab responses to HuSA. 1,3 beta-Glucan did not significantly affect Ab responses to HuSA. All birds challenged with PAMP showed a decreased BW. Higher total Ab titers to infectious bursal disease and infectious bronchitis were found in birds challenged with LTA. The present results indicate that i.t. administered PAMP affect the humoral immune responsiveness of poultry, which may lead to an enhanced status of immune reactivity. Furthermore, our results suggest that the hygienic status of the environment influences BW (gain). The consequences of immune modulation by airborne PAMP or hygienic conditions in chicken husbandry for vaccine delivery and immune responsiveness of poultry are discussed.
authors.affiliation: Section of Immunology, Adaptation Physiology Group, and Cell Biology and Immunology Group, Department of Animal Sciences, Wageningen University, Marijkeweg 40, 6709 PG Wageningen, the Netherlands.
authors.forename: T C W
authors.initials: TC
authors.lastname: Ploegaert
authors.forename: G
authors.initials: G
authors.lastname: De Vries Reilingh
authors.forename: M G B
authors.initials: MG
authors.lastname: Nieuwland
authors.forename: A
authors.initials: A
authors.lastname: Lammers
authors.forename: H F J
authors.initials: HF
authors.lastname: Savelkoul
authors.forename: H K
authors.initials: HK
authors.lastname: Parmentier
mesh_terms: D000818:Animals; D018175:Birnaviridae Infections / Q000517:prevention & control / Q000662:veterinary; D002645:Chickens / Q000276:immunology*; D018352:Coronavirus Infections / Q000517:prevention & control / Q000662:veterinary; D005260:Female; D006801:Humans; D001351:Infectious bronchitis virus / Q000276:immunology; D007243:Infectious bursal disease virus / Q000276:immunology; D008070:Lipopolysaccharides / Q000276:immunology*; D012709:Serum Albumin / Q000276:immunology*; D013682:Teichoic Acids / Q000276:immunology*; D014132:Trachea; D014765:Viral Vaccines / Q000276:immunology; D015430:Weight Gain; D015054:Zymosan / Q000276:immunology*
chemical_list: D008070:Lipopolysaccharides; D012709:Serum Albumin; D013682:Teichoic Acids; D014765:Viral Vaccines; C009900:lipoteichoic acid; D015054:Zymosan